A Case of Atypical Delayed and Prolonged Hematologic Toxicity With Azacitidine in Chronic Myelomonocytic Leukemia (CMML) and Review of Literature

Por Elli, Elena, Cecchetti, Caterina, Belotti, Angelo, Borin, Lorenza, Pogliani, Enrico Maria
Publicado em 2012

Long-term and low-dose of busulfan is a safe and effective second-line treatment in elderly patients with essential thrombocythemia resistant or intolerant to hydroxyurea

Por Renso, Rossella, Aroldi, Andrea, Pioltelli, Pietro, Gambacorti-Passerini, Carlo, Elli, Elena Maria
Publicado no Blood Cancer J (2018)

Iron Chelation Therapy with Deferasirox in the Management of Iron Overload in Primary Myelofibrosis

Por Elli, Elena Maria, Belotti, Angelo, Aroldi, Andrea, Parma, Matteo, Pioltelli, Pietro, Pogliani, Enrico Maria
Publicado em 2014

Good Outcome for Very High Risk Adult B-cell Acute Lymphoblastic Leukaemia Carrying Genetic Abnormalities t(4;11)(q21;q23) or t(9;22)(q34;q11), if Promptly Submitted to Allogeneic...

Por Parma, Matteo, Viganò, Clara, Fumagalli, Monica, Colnaghi, Federica, Colombo, Arianna, Mottadelli, Federica, Rossi, Vincenzo, Elli, Elena, Terruzzi, Elisabetta, Belotti, Angelo, Cazzaniga, Giovanni, Pogliani, Enrico Maria, Pioltelli, Pietro
Publicado no Mediterr J Hematol Infect Dis (2015)

The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B(2) assay as an evaluation tool of different asp...

Por De Stefano, Valerio, Rocca, Bianca, Tosetto, Alberto, Soldati, Denise, Petrucci, Giovanna, Beggiato, Eloise, Bertozzi, Irene, Betti, Silvia, Carli, Giuseppe, Carpenedo, Monica, Cattaneo, Daniele, Cavalca, Viviana, Dragani, Alfredo, Elli, Elena, Finazzi, Guido, Iurlo, Alessandra, Lanzarone, Giuseppe, Lissandrini, Laura, Palandri, Francesca, Paoli, Chiara, Rambaldi, Alessandro, Ranalli, Paola, Randi, Maria Luigia, Ricco, Alessandra, Rossi, Elena, Ruggeri, Marco, Specchia, Giorgina, Timillero, Andrea, Turnu, Linda, Vianelli, Nicola, Vannucchi, Alessandro M., Rodeghiero, Francesco, Patrono, Carlo
Publicado no Blood Cancer J (2018)

Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms

Por De Stefano, Valerio, Carobbio, Alessandra, Di Lazzaro, Vincenzo, Guglielmelli, Paola, Iurlo, Alessandra, Finazzi, Maria Chiara, Rumi, Elisa, Cervantes, Francisco, Elli, Elena Maria, Randi, Maria Luigia, Griesshammer, Martin, Palandri, Francesca, Bonifacio, Massimiliano, Hernandez-Boluda, Juan-Carlos, Cacciola, Rossella, Miroslava, Palova, Carli, Giuseppe, Beggiato, Eloise, Ellis, Martin H., Musolino, Caterina, Gaidano, Gianluca, Rapezzi, Davide, Tieghi, Alessia, Lunghi, Francesca, Loscocco, Giuseppe Gaetano, Cattaneo, Daniele, Cortelezzi, Agostino, Betti, Silvia, Rossi, Elena, Finazzi, Guido, Censori, Bruno, Cazzola, Mario, Bellini, Marta, Arellano-Rodrigo, Eduardo, Bertozzi, Irene, Sadjadian, Parvis, Vianelli, Nicola, Scaffidi, Luigi, Gomez, Montse, Cacciola, Emma, Vannucchi, Alessandro M., Barbui, Tiziano
Publicado no Blood Cancer J (2018)